Member Info for CTSFO

Being serious, we don’t know if anyone will take an interest in RUAs product and develop heart valves from it.

But

We’re a decent length of time into the trial and we haven’t had an RNS saying the major isn’t interested. So that’s good.

This is important:

“ That's what the global company are doing now and have been for the last 6 months - testing to ISO 5840 requirements.

They don't make up their own tests only to have to do another mandatory different set of tests - they ain't stupid by duplicating costs and time.”

RUA is 6 months ahead of the major with in-house data. If the major’s 6 month / 400 & 200 million cycle data is the same as RUA’s at the equivalent point - then the major may seek to see RUA’s most recent data covered by a NDA. It might accept the performance data will match for its valve extrapolated out. And be more interested in entering into a JV / merger / TO earlier rather than later.

When you remortgage the house and buy RUA with the cash!!!

Couldn’t agree more. The potential for a takeover is very real here. RUA structural heart or the entire group? Personally I think a major buying everything makes most sense. Would this trigger a bidding war? Jimzi’s comments very important here as well. The potential to disrupt the source and supply chain of xenografts is very real. Whilst this product is cheaper and better. Another point, plenty of lab work being done on polymeric valves in universities. Echoing other posts, not sure how many others have the science to improve AND ability to upscale supply? I’ve got to repeat myself, this is a hidden gem. Tine to load up.

GLA.

I’m guessing the Final Results in July will include an update on the in-house testing of the heart valves. Approx another 6 months of data. That’s got to be close to double the minimum number of cycles ISO expect. Fingers crossed and the best of luck everyone.

APOLOGY AND EXPLANATION.

My post looks like it’s knocking the company a bit. I’m very sorry. That wasn’t the intention. It was a reply to:

“ I assume that means that if the heart valve company with the MTA wanted to move forward they could use RUA's material in their existing regulated valve products without having to go through regulatory trials. That's massive for RUA and no doubt a major factor on why they have embarked on a deal for material rather than create a heart valve for licensing”

Which I think suggested full testing wouldn’t be necessary. Sorry for not making this clear.

I don’t see how RUA’s product will be anything but game changing here.

Unfortunately, if a manufacturer changes the polymer used within its valve replacement it will be classed as a new device. It will need to be tested to ISO 5840 requirements. The FDA / MHRA / EMA etc will then authorise and determine what post implant follow up is required.

Hi Crowfoot. It’s an interesting discussion. I’m not suggesting anything illegal, but it would be useful to know what discussions Dr C has had with CPX and when. Buying into the company after the warning of a potential administration but before the placing certainly encouraged me to think the company was actually safe. The placing came as a surprise following this. But we had been warned. Buying more shares and becoming a NED certainly suggests a better longterm outlook for the company. No point in putting good money after bad? It’s also worth thinking of 3 NEDs joining, not just Dr C. We can but wait and see. Good luck.

Hope everyone has a great weekend. The light has been upgraded and turned on at the end of the tunnel!

Patents, JV update, order book, strategic review by the good Dr?

It’s going to be like Christmas Morning here at 08:00 on Monday. Fingers crossed Santa’s good to us! 🎅💰💰💰💰💰💰🤗

Any share that goes up 200% (near as) is going to get some interest. Hopefully people will DYOR&DD and see this company has the potential which has attracted some very serious people onto the board, AND into the shareholder pool. Not here just for the paycheque and tea & biscuits. It’s going to get very interesting here. Every other capacitor maker is now looking over their shoulder. Roll on the updates on patents. GLA.

Excellent post, thank you.

Yep, 0.4 by end of July. A reasonable timeframe.

Up and down faster than a 17 year olds wrist. Let’s hope we have a happy ending to the day!

NURSE NURSE!!! Don’s locked himself in the office and is on the internet. NURSE!!!!!

Dr Cooley has also invested heavily with his own hard earned. 12% of the company, even at a lower sp, is still an impressive vote of confidence. But not dismissing your post. Tomorrow, and the coming weeks, will be very interesting.

Bound to be some profit taking, but tomorrow will be very interesting / unpredictable. The new lineup of the BoD brings tremendous value to the company. Get the popcorn ready.

Fair comment. Not my best posts ever… but I know this is a hidden gem of share. Even more so now. Good luck.

“ Why buy now it’s going down without news”

This sums up so much of AIM at present. It’s a reasonable question. None of us knows when the news will hit. But we’ve seen how rapidly this share spikes. I’d rather add close to bottom, and accept a small further drop, than risk being locked out. But everyone has their own view on this. GLA.

IntraVnous posted this:

“ Just to follow up my last post, Bill Brown has a tendency to provide a shopping bag full of updates in one RNS. So, likely as not, the next update will be like the last one, a bit about each division with the odd tidbit thrown in to each.”

It’s possible we’ll get an update on the number of cycles the in-house valve AWT has performed. We’re bound to be >400 million cycles. If the valve characteristics - to me especially the energy efficiency - stay the same, the industry is looking at a potential game changer. IMHO.